N@N

Graig Suvannavejh Maintained (AXSM) at Strong Buy with Increased Target to $109 on, Mar 28th, 2024

Graig Suvannavejh of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $108 to $109 on, Mar 28th, 2024.

Graig has made no other calls on AXSM in the last 4 months.

There are 9 other peers that have a rating on AXSM. Out of the 9 peers that are also analyzing AXSM, 0 agree with Graig's Rating of Hold.

These are the ratings of the 9 analyists that currently disagree with Graig

---

• David Hoang of "Citigroup" Maintained at Strong Buy with Increased Target to $127 on, Tuesday, March 26th, 2024
• Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $150 on, Tuesday, March 26th, 2024
• Leonid Timashev of "RBC Capital" Maintained at Buy with Increased Target to $128 on, Tuesday, March 26th, 2024
• Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $190 on, Tuesday, March 26th, 2024
• Joel Beatty of "Baird" Initiated at Buy and Held Target at $108 on, Tuesday, March 19th, 2024
• Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $103 on, Wednesday, February 21st, 2024
• Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $125 on, Wednesday, February 21st, 2024
• Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
• David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024

Contributing Sources

---